Loading…

Severe haemophilia A children on low‐dose tertiary prophylaxis showed less joint deterioration and better maintenance of functional independence than children on on‐demand treatment: A 6‐year follow‐up study

Background In countries with limited resource, haemophilia patients have to choose low‐dose prophylaxis or on‐demand treatment (ODT) because of economic constraints. Whether low‐dose prophylaxis can achieve better joint function outcome than ODT over long‐term remains unclear. Aim To investigate the...

Full description

Saved in:
Bibliographic Details
Published in:Haemophilia : the official journal of the World Federation of Hemophilia 2020-09, Vol.26 (5), p.779-785
Main Authors: Liu, Ying, Chen, Lixia, Li, Kuixing, Shi, Mingnan, Poon, Man‐Chiu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background In countries with limited resource, haemophilia patients have to choose low‐dose prophylaxis or on‐demand treatment (ODT) because of economic constraints. Whether low‐dose prophylaxis can achieve better joint function outcome than ODT over long‐term remains unclear. Aim To investigate the long‐term effect of low‐dose tertiary prophylaxis versus ODT on joint health in severe haemophilia A children. Methods This was a retrospective study. We enrolled and followed 34 severe haemophilia boys in China receiving on‐demand treatment (n = 18) or low‐dose prophylaxis (10‐15 IU/kg, 2‐3 times per week) for a medium‐term (6‐18 months, n = 9) or longer‐term (19‐30 months, n = 7). We evaluated their haemophilia joint health score (HJHS) 2.1 and functional independence score in haemophilia (FISH) at baseline and at their 6‐year follow‐up visits. Their annual bleeding rate (ABR) and annual joint bleeding rate (AJBR) were also recorded. Results During the 6‐year follow‐up period, ABR and AJBR were similar between the 2 prophylaxis groups, with each of the 2 prophylaxis group rates being significantly better (lower) than the ODT group (P 
ISSN:1351-8216
1365-2516
DOI:10.1111/hae.14016